Canada
# |
Name |
Net Cash Used Provided By Financing Activities |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 21.85 M
|
Dec. 31, 2023 | USD 6.79 | -4.77% |
|
Canada |
|
2 |
USD 8.02 M
|
Dec. 31, 2023 | USD 4.39 | 2.76% |
|
Canada |
|
3 |
USD 6.27 M
|
Oct. 31, 2024 | USD 1.49 | 8.76% |
|
Canada |
|
4 |
USD -14.64 M
|
Dec. 31, 2023 | USD 2.96 | 1.10% |
|
Canada |
The Mental Health company in Canada with the highest Net Cash Used Provided By Financing Activities is Mind Medicine (MindMed) Inc. (NasdaqGS: MNMD) at USD 21.85 M.
The Mental Health company in Canada with the lowest Net Cash Used Provided By Financing Activities is HLS Therapeutics Inc. (Toronto Stock Exchange: HLS.TO) at USD -14.64 M.
The top 10 Mental Health companies in Canada by Net Cash Used Provided By Financing Activities are Mind Medicine (MindMed) Inc., WELL Health Technologies Corp., Clearmind Medicine Inc. and HLS Therapeutics Inc..
The bottom 10 Mental Health companies in Canada by Net Cash Used Provided By Financing Activities are HLS Therapeutics Inc., Clearmind Medicine Inc., WELL Health Technologies Corp. and Mind Medicine (MindMed) Inc..